|This Slide: #24 of 100|
Slide #24. BioTelemetry, Inc. — Mednet Healthcare Technologies, Inc.
BioTelemetry, Inc. (NASDAQ:BEAT)
Mednet Healthcare Technologies, Inc.
BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a significant victory in the patent infringement case against Mednet Healthcare Technologies, Inc. and its subsidiaries, Heart-Care Corporation of America, Universal Medical Inc., and Universal Medical Laboratory, Inc. ("Mednet"), as well as other named defendants. Mednet entered into a consent judgment, declaring that the Mednet entities infringed on five patents owned by BioTelemetry and its subsidiary, Braemar Manufacturing, and that all five patents are valid.
BioTelemetry is a remote medical technology company focused on delivery of health information. Co. provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials and original equipment manufacturing that serves both healthcare and clinical research customers. Co. operates under two reportable segments: Healthcare, which is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders; and Research, which is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials.
BEAT SEC Filing Email Alerts Service
Open the BEAT Page at The Online Investor »
Buy (3.40 out of 4)
(ranked higher than approx. 59% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite